Svår sepsis och septisk chock kräver omedelbart omhändertagande

Lakartidningen

Volumn 108, Issue 6, 2011, Pages 271-275

  Gårdlund, Bengt ^a   Cronqvist, Jonas ^b   Follin, Per ^c   Furebring, Mia ^d   Gille Johnson, Patrik ^a   Sjölin, Jan ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Smittskyddsenheten ^*  (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ARTICLE; DIFFERENTIAL DIAGNOSIS; EMERGENCY; FLUID THERAPY; HEALTH CARE QUALITY; HUMAN; INTENSIVE CARE; OXYGEN THERAPY; SEPSIS; SEPTIC SHOCK; VITAL SIGN;

ADULT; ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; EMERGENCIES; FLUID THERAPY; HUMANS; INTENSIVE CARE; OXYGEN INHALATION THERAPY; QUALITY ASSURANCE, HEALTH CARE; SEPSIS; SHOCK, SEPTIC; VITAL SIGNS;

EID: 79551712501     PISSN: 00237205     EISSN: 16527518     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34: 1589-96.
2. De Miguel-Yanes JM, Andueza-Lillo JA, González-Ramallo VJ, Pastor L, Muñoz J. Failure to implement evidence-based clinical guidelines for sepsis at the ED. Am J Emerg Med. 2006;24:553-9.
3. Lala HM, Mills GD, Barratt K, Bonning J, Manikkam NE, Martin D. Meningococcal disease deaths and the frequency of antibiotic administration delays. J Infect. 2007;54:551-7.
4. Garnacho-Montero J, García-Cabrera E, Diaz-Martín A, Lepe-Jiménez JA, Iraurgi-Arcarazo P, Jiménez-Alvarez R, et al. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment. Scand J Infect Dis. 2010;42:185-92.
5. Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010; 38:1045-53.
6. Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW. Mortality in emergency department sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule. Crit Care Med. 2003;31:670-5.
7. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32: 1637-42.
8. Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis. 1999;29:60-6.
9. Raineri E, Pan A, Mondello P, Acquarolo A, Candiani A, Crema L. Role of the infectious disease specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control. 2008; 36:283-90.
10. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
11. Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32: S451-4.
12. Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med. 1990;112:492-8.
13. Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med. 1991;19:1352-6.
14. Rivers EP, McIntyre L, Morro DC, Rivers KK. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ. 2005;173:1054-65.